ConvaTec Group (LON:CTEC) Receives “Buy” Rating from Berenberg Bank

Berenberg Bank restated their buy rating on shares of ConvaTec Group (LON:CTEC) in a research note published on Wednesday morning,London Stock Exchange reports. The brokerage currently has a GBX 310 ($4.00) target price on the stock.

ConvaTec Group Stock Performance

Shares of CTEC traded down GBX 3 ($0.04) during trading hours on Wednesday, hitting GBX 266.40 ($3.43). The company’s stock had a trading volume of 30,871,107 shares, compared to its average volume of 13,549,809. ConvaTec Group has a 52-week low of GBX 211.80 ($2.73) and a 52-week high of GBX 295.20 ($3.81). The company has a market cap of £6.77 billion, a price-to-earnings ratio of 44.86, a PEG ratio of 0.93 and a beta of 0.64. The company has a debt-to-equity ratio of 85.32, a current ratio of 2.26 and a quick ratio of 0.96. The business has a 50 day simple moving average of GBX 239.15 and a two-hundred day simple moving average of GBX 232.91.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.